Sign in
Taking peopleNo phase

The Peripheral(-Muscle) Oxygenation and Perfusion Score as a New Non-invasive Tool to Predict Elevations in C-reactive Protein Levels in Neonates

Key facts

Who runs it
Medical University of Graz
Where
Austria1 site in 1 countryChoose a country to see its sites
Trial code
Status
Recruiting
People taking part
93 people, planned
Started
27 Nov 2025
Expected to end
1 May 2028
Type of study
Observational
Treatments tested
  • POP-Score Assessment
  • Near-Infrared Spectroscopy (NIRS)
Record updated
14 May 2026

Who can take part

Age
0 hours to 6 hours
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 11 criteriaShow less

Who can take part

  • birth weight ≥ 2000 grams
  • Signs of respiratory distress at time-point of inclusion (tachypnoea >60/min, grunting, intercostal/subcostal/jugular retractions, nasal flaring, supplemental oxygen or respiratory support)
  • Decision to conduct full life support
  • Written informed consent obtained within the first 6 hours after birth, before inclusion in the study
  • Age < 6 hours

Who cannot take part

  • Age > 6 hours
  • No decision to conduct full life support
  • No written informed consent
  • Birth weight < 2000 grams
  • Severe congenital malformations,
  • Umbilical cord artery pH <7.20

This trial is currently available in Austria.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

This is a prospective, single-center Phase II observational study investigating the predictive value of the "Peripheral(-muscle) Oxygenation and Perfusion Score" (POP-Score), a novel non-invasive composite index, for early detection of infection/inflammation in neonates. The POP-Score combines peripheral muscle oxygenation measured via near-infrared spectroscopy (NIRS) with routinely monitored clinical parameters (heart rate, oxygen saturation, systolic blood pressure, and subcutaneous fat thickness). The study aims to determine the optimal cut-off value of the POP-Score measured within the first 6 hours after birth to predict elevated C-reactive protein (CRP ≥20 mg/L) within 48 hours. Additionally, multi-site NIRS measurements (cerebral, peripheral muscle, intestinal, and flank) will be evaluated to assess their association with inflammation. The study includes term and moderate-to-late preterm neonates (birth weight ≥2000g) with respiratory distress, admitted to the neonatal intensive care unit at the Medical University of Graz.

The group in the trial

  • Observational cohort

    This cohort includes term and moderate-to-late preterm neonates (birth weight ≥ 2000g) with respiratory distress within the first 6 hours after birth, admitted to the neonatal intensive care unit. All enrolled neonates undergo non-invasive monitoring to assess the predictive value of the POP-Score for identifying elevated CRP (≥20 mg/L) within the first 48 hours after birth. The cohort will also be analyzed to evaluate differences in multi-site NIRS measurements (peripheral muscle, cerebral, intestinal, and flank) between those with and without CRP elevation.

    Treatment: POP-Score Assessment and Near-Infrared Spectroscopy (NIRS)

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
The Peripheral(-Muscle) Oxygenation and Perfusion Score (POPScore) a New Non-invasive Tool to Predict Elevations in C-reactive Protein Levels in Neonates - a Prospective Phase II Observational Study
Record updated
14 May 2026